Dosulepin

DRUG3 trials

Sponsors

Universitair Medisch Centrum Utrecht, All India Institute of Medical Sciences, Bhubaneswar

Conditions

Depressive EpisodeMajor depressive disorderSomatic Symptom Disorder (DSM-V)

Phase 3

A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for major depressive disorder compared to treatment as usual in subjects who had a first-time treatment failure on their first-line treatment.

RecruitingCTIS2023-506617-21-00

Universitair Medisch Centrum UtrechtMajor depressive disorder

Start: 2024-08-29Target: 360Updated: 2025-04-17

Phase 4

Effect of Venlafaxine Versus Dosulepin in Pain Predominant Somatic Symptom Disorder

RecruitingNCT06803485

All India Institute of Medical Sciences, BhubaneswarSomatic Symptom Disorder (DSM-V)

Start: 2025-03-11End: 2026-11-30Target: 84Updated: 2025-09-24

Unknown Phase

Study of the Effect of Antidepressant Drugs on Neurotrophic Factors in Patients With Depression

CompletedNCT03126188

All India Institute of Medical Sciences, BhubaneswarDepressive Episode

Start: 2017-04-05End: 2018-02-28Updated: 2018-07-11